NY Requirements Blog
Infection Control & Barrier Precautions, Education for Prescribing Controlled Substances, and Child Abuse Reporter Training
Meet Your New York Continuing Requirements Quickly & Affordably.
Archives
Posted by Katrina Poggio
Child abuse fatalities are rising, especially in Texas and Indiana, according to recent reports. The United States Department of Health and Human Services released a Child Maltreatment 2016 report in early February 2018. The report, which covers the 2016 fiscal year, shows a 7 percent increase in child deaths related to abuse when compared to 2015. The 49 states that participated reported 1,700 fatalities as a result of child maltreatment. In 2015, there were 1,589 fatalities reported, according to a news release. “Helping state child welfare agencies prevent and address child abuse and neglect is one of our top priorities this year,” said Steven Wagner, acting assistant secretary for children and families at ACF, in a news release. “Collaborating with state child protective services helps us collect case-level data to better understand what’s occurring in a home when a child is neglected or abused.” Of the total 3.5 million children who were t...

Posted by Katrina Poggio
The National Cancer Institute at the National Institutes of Health estimates that more than 252,700 women will be diagnosed with breast cancer in just this year alone. Of those affected, about 40,600 people will die of the disease, but a new drug may help bring those numbers down and give a fighting chance to those battling the most common form of cancer in the U.S. The Food and Drug Administration approved AstraZeneca’s Lynparza,  on January 12, 2018 to help treat those impacted by breast cancer. It is the first time ever that a drug has been approved to help treat patients with metastatic breast cancer who also have a BRCA gene mutation, according to an FDA press release. “This class of drugs has been used to treat advanced, BRCA-mutated ovarian cancer and has now shown efficacy in treating certain types of BRCA-mutated breast cancer,” said Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Off...